To investigate the effects of glycyl-glutamine (Gly-Gln) on the growth performance and body composition in Yue-Huang broilers, two hundreds and seventy 9-d-old birds were randomly allocated to 3 groups of 90 birds each, incorporating 3 cages per group. All the birds were offered a commercial starter feed supplemented with 0, 0.01 or 0.05 mg Gly-Gln per kg for next 5 weeks, then given a commercial grower feed for another 5 weeks. The results showed that Gly-Gln could not only significantly increase the body weight of Yue-Huang broilers but also enhanced breast muscle and leg muscle yields, while it declined abdominal fat percentage in a dose-dependent manner. The concentration of triglyceride and total cholesterol (T-CHO) in serum and that of T-CHO in pectoralis major muscle were reduced with the up-regulated mRNA expression of peroxisome proliferatoractivated receptors α (PPAR-α) and down-regulated transcript levels of acetyl-CoA carboxylase (ACC) and sterol regulatory element binding protein-2 (SREBP-2).
INTRODUCTION
Glutamine (Gln), a non-essential amino acid, is the most abundant free amino acid in whole blood and an important respiratory fuel and nucleotide precursor for the gastrointestinal tract likewise the immune system (Melis et al., 2004) . In stressed states e.g., trauma and sepsis, the intestinal uptake of Gln from the blood is significantly increased (Nemoto et al., 1996) . Several lines of evidence from animal studies and controlled clinical trials has confirmed that the nutritional support with supplemental glutamine dipeptide positively influences protein synthesis (Petersson et al., 1994) , nitrogen balance (Morlion et al., 1998) , immune status (Powell-Tuck, 1999) , gut integrity, morbidity, rehabilitation and outcome (van der Hulst et al., 1993; Chang et al., 2001) .Therefore, the highly soluble glycyl-glutamine (Gly-Gln) has been widely applied in total parenteral nutrition as the carrier of Gln (Furst et al., 1997) . Furthermore, a study done by our group found that Gly-Gln could significantly increase feed conversion ratio, growth performance and dramatically reduce diarrhoea occurring rate (Huang et al., 2004) .
Although a lot of experiments have been conducted on the nutritional effects of Gln or Gly-Gln in mammal and rodent, little affection has beed directed at the effect of the same in avian species. The main purpose of the present study was to investigate the effects of Gly-Gln, a dipeptide on the growth performance, body composition, level of triglyceride (TG), total cholesterol (T-CHO) in serum, liver and muscle as well as determine the expression levels of lipid metabolism-associated genes in liver.
MATERIAL AND METHODS

Animals, treatments and management
Two hundreds and seventy 9-d-old Yue-Huang broilers (a local breed in the south of China) obtained from a local hatchery (Experimental Broiler Breeder Farm of South China Agricultural University, Guangzhou, China) were weighed individually and allocated to 3 groups of 90 birds each involving 3 cages per group. The birds from each cage were randomly offered a commercial starter feed (obtained from Institute of Animal Science Guangdong, Academy of Agricultural Sciences) with the composition of, %: soya meal 26, maize 60, fish meal 3, bran 5.3, rape seed oil 4.7, premix with vitamins and minerals 1. Calculated analysis revealed the feed to contain 20% crude protein, 2.900 kcal/kg metabolizable energy, 0.52% methionine and 1.10% lysine supplemented with 0 (control), 0.01 (LCG) or 0.05 (HCG) mg glycyl-glutamine (Gly-Gln) (Tianjin Tiancheng Pharmaceutical Company, China) per kg for 5 weeks. Then, all the birds were transferred to a commercial grower feed (22% soyabean meal and 8.7% rape seed oil) for 5 weeks. Feed and water were offered ad libitum. The chickens were kept with continuous light during the first 3 days and then, 16 h lighting daily thereafter. The room temperature was initially set at 35°C and was gradually reduced to 22°C at week 3 and kept constant thereafter.
Growth performance and carcass composition
Liveweights on a cage basis were recorded at week 3, 5, 7 and 10. At the end of the experiment, 20 birds were sacrificed to determine the abdominal fat percentage (AFP), the breast meat yield (BMY) and the leg meat yield (LMY).
Serum and tissue analysis
At week 5, 20 non-fasted birds with weight close to the average body weight were selected from each group. Blood samples were obtained from the arteria carotis after decapitation and centrifuged at 3000 g for 15 min and the sera stored at -20°C. About 10 g of pectoralis major muscle (PM) and liver were quickly excised, washed and snap frozen at -80°C until analysis. The concentration of triglyceride (TG) in serum and liver, and that of total cholesterol (T-CHO) in serum and PM were measured by commercial assay kit (Nanjing Jiancheng Biological Product Co., Ltd., China). All the analyses were carried out according to the manufacturer's instructions.
Quantitative reverse transcriptase polymerase chain reaction analysis
The relative quantitative RT-PCR was performed to detect the expression level of lipid metabolism related genes (Dieffenbach et al., 2004) . Total RNAs were isolated from the liver by one-step extraction method using Trizol kit (SBS Gene Co., Ltd., Peking, China) and purified by DNase I (RNase free) (TaKaRa, Japan) to eliminate the genomic DNA contamination. RNA was assessed by agarose gel electrophoresis for integrity and quantified spectrophotometrically. All cDNAs were transcripted by 10 U MMLV (Promega, USA) and 5 µM Oligo dT (10) in each 20 µl total reverse transcript reaction from 2 µg total RNA. Gene specific primer pairs were designed by Primer Premier 5.0 software according to the Genbank sequences for β-actin, ACC, PPAR α and SREBP-2 (Table 1) . The 25 µl PCR amplification reaction system included 2 µl cDNA, 1.8 mM MgCl 2 , 
Statistical analysis
Data generated were analysed using one-way analysis of variance by SPSS 11.0 software with post hoc analyses being carried out by Tukey's honestly significant difference test. Differences between groups were considered statistically significant at P<0.05. Table 2 demonstrated that GlyGln could not only significantly increase the body weight of Yue-Huang broilers but also showed an energy re-distributional function with enhanced BMY and LMY and a declined AFP in a dose-dependent manner. Serum and tissue parameters. It can be seen from the Table 3 that Gly-Gln could dose-dependently decrease the serum concentration of TG. However, only 0.01 mg Gly-Gln significantly lowered the liver TG content. The concentration of T-CHO in sera and PM were dose-dependently decreased by Gly-Gln supplementation. In comparison with the control, 0.05% Gly-Gln treated group confirmed the wighest decreased level of 41.4 and 53% in relation to T-CHO concentration in serum and PM respectively. Hepatic PPAR-α, ACC and SREBP-2 mRNA expression. The mRNA expression level of ACC and SREBP-2 in the liver of Yue-Huang broilers could be dosedependently down-regulated by Gly-Gln treatment ( Figure 1B,C) , while that of PPAR-α was up-regulated ( Figure 1A ). All the mRNA expression level showed significant difference in 0.05 mg/kg Gly-Gln treated group compared to the control group. 
RESULTS
Growth performance and body composition.
DISCUSSION
Muscle tissue is a major site for glutamine synthesis in animals and contains over 90% of the whole-body glutamine pool (Newsholme and Parry-Billings, 1990; Newsholme et al., 2003) . The release of glutamine from skeletal muscle is stimulated during stress conditions such as injury and burns (Hammarqvist et al., 2001) . This process could be reversed by the nutritional support of glutamine (Roth et al., 1988) . Our present study showed that Gly-Gln supplementation resulted in an increase of BMY, LMY and the body weight of birds which is similar to the observations made in rats (Tannuri et al., 2000) and pig (Huang et al., 2004 ). An earlier study demonstrated an enhanced shearing strength of pectoralis major muscle in yellow-feathered chickens treated with Gly-Gln (Shu et al., 2006) . The above observations give the indication that Gly-Gln could enhance avian protein deposition, probably, through decreasing the amino acids mobilization in muscles.
In this study, the energy re-distributional function of Gly-Gln was also indicated by way of a decreased AFP in Yue-Huang broilers. As expected, the concentration of TG and T-CHO in serum and the deposition of these in adipose and muscle tissue were significantly reduced with Gly-Gln supplementation, which suggest an important role of Gly-Gln in the avian lipid metabolism. In rodent, it has been reported that L-glutamine supplementation of a high fat diet attenuates hyperglycaemia and hyperinsulinaemia in C57BL/6J mice (Opara et al., 1996) . Moreover, Xia et al. (2003) revealed that glutamine, as a major nutrient, could increased abundance of the mRNAs encoding the metabolic enzymes in mouse, muscle carnitine palmitoyl transferase I and muscle adenylosuccinate synthetase. In avian, however, the lipid metabolism is much different from mammal and rodent. About 80-85% of TG (Griffin et al., 1992) and 90% of the total T-CHO (Qureshi et al., 1983) were reportedly de novo synthesized by the liver of chickens. During the synthesis of TG and cholesterol in liver, key enzymes and their transcript factors are closely associated with the body's fat deposit level. ACC, a rate-limiting enzyme, catalysed the first step for the synthesis of fatty acid. ACC defective mice showed a 50% decrease in their body fat deposit level (Abu-Elheiga et al., 2001; Tong, 2005) . Peroxisome proliferator-activated receptors (PPARs) are a key family of nuclear transcription factors which participate in the process of lipid homeostatic regulations (Issemann and Green, 1990) . The activation of PPAR-α in liver could promote ingestion, combination, and oxidized metabolism of fatty acid (Bocher et al., 2002) . As a major regulation and control factor for T-CHO homeostasis, SREBP-2 promotes intake and synthesis of T-CHO in liver (Eberle et al., 2004) . In this study, we found that Gly-Gln could dose-dependently downregulate ACC and SREBP-2 mRNA expression, but up-regulate that of PPAR-α. It could be stated that Gly-Gln might reduce the de novo synthesis of fatty acids and cholesterol in the liver and thus, increase fatty acids oxidization which invariably would bring about the decline of fat and cholesterol deposition. For the crucial bioactivities of cholesterol (Saini et al., 2004) , the content of T-CHO in animal products have been regarded as an important reference indices to evaluate meat qualities. This study may hopefully provide a favourable basis for low cholesterol meat production.
Though the mRNA expressions of avian hepatic lipid metabolism related genes were regulated by Gly-Gln supplementation, the exact mechanism remains unclear. Recently, Gly-Gln, which is also called β-endorphin (30-31), was identified as a neuron dipeptide generated from the two amino acids at the carboxyl terminal of β-endorphin 1-31 and belongs to the proopiomelanocortin (POMC) system (Krude and Gruters, 2000) . Several lines of evidences suggested a wide range of biological activities of Gly-Gln, which can not only participate in immunological regulation, stimulate lymphocytosis, improve activities of natural killer cells (Ghanta et al., 1991) , but also inhibit the dependence on opioid drugs (Cavun et al., 2005) . Now that the physiological function of thermogenesis and energy equilibrium of POMC system has been well established (Low, 2004) , whether the effects of Gly-Gln on the avian lipid metabolism act through the single Gln or the neuropeptide remains to be investigated.
